pulmonary arterial hypertension Archives -

For some years industry observers have been asking what Merck & Co can do to reduce its reliance

Merck turns to cardiovascular pipeline for its post-Keytruda future

https://pharmaphorum.com/news/merck-turns-to-cardiovascular-pipeline-for-its-post-keytruda-future/

Gilead has paid $97 million to resolve claims by US authorities that it acted illegally by using a

Gilead pays $97m to resolve US illegal kickback claims

https://pharmaphorum.com/news/gilead-pays-97m-to-resolve-us-illegal-kickback-claims/

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle

Moderna broadens R&D scope with Vertex, Chiesi alliances

https://pharmaphorum.com/news/moderna-broadens-rd-scope-with-vertex-chiesi-alliances/

But drug flops in two other indications.

Gilead to take selonsertib into phase 3 in NASH

https://pharmaphorum.com/news/gilead-take-selonsertib-phase-3-nash/

pulmonary arterial hypertension